SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-18-000092
Filing Date
2018-07-30
Accepted
2018-07-30 17:13:01
Documents
15
Period of Report
2018-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim8k.htm 8-K 30193
2 EXHIBIT 99.1 pr.htm EX-99.1 325763
3 EXHIBIT 99.2 q218presentation.htm EX-99.2 16657
4 primage1a09.jpg GRAPHIC 3525
5 q218presentation001.jpg GRAPHIC 116272
6 q218presentation002.jpg GRAPHIC 221244
7 q218presentation003.jpg GRAPHIC 66848
8 q218presentation004.jpg GRAPHIC 107045
9 q218presentation005.jpg GRAPHIC 57472
10 q218presentation006.jpg GRAPHIC 100372
11 q218presentation007.jpg GRAPHIC 76210
12 q218presentation008.jpg GRAPHIC 66883
13 q218presentation009.jpg GRAPHIC 186134
14 q218presentation010.jpg GRAPHIC 77779
15 q218presentation011.jpg GRAPHIC 114792
  Complete submission text file 0001267602-18-000092.txt   2020531
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 6789905740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 18978519
SIC: 2834 Pharmaceutical Preparations